Filing Details

Accession Number:
0001553878-13-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-26 18:53:00
Reporting Period:
2013-03-25
Filing Date:
2013-03-26
Accepted Time:
2013-03-26 18:53:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192603 P Kevin Starr C/O Alnylam Pharmaceuticals
300 Third Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-25 26,631 $0.95 26,631 No 4 M Direct
Common Stock Disposition 2013-03-25 26,631 $23.56 0 No 4 S Direct
Common Stock Acquisiton 2013-03-26 26,000 $0.95 26,000 No 4 M Direct
Common Stock Disposition 2013-03-26 26,000 $23.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-03-25 26,631 $0.00 26,631 $0.95
Common Stock Stock Option (Right to Buy) Disposition 2013-03-26 26,000 $0.00 26,000 $0.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,000 2013-09-24 No 4 M Direct
0 2013-09-24 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2012.
  2. Sale prices ranged from $23.28 to $23.88.
  3. Sale prices ranged from $23.13 to $23.82.
  4. The stock option vested as to 25% of the shares on the first year anniversary of the grant date and ratably with respect to the remaining shares on the last day of each month for the three years thereafter.